Asklepios Biopharmaceutical Inc., of Research Triangle Park, N.C., appointed Don Haut chief business officer.

Glycomimetics Inc., of Rockville, Md., appointed Myra Rosario Herrle vice president, regulatory affairs.

Morphic Therapeutic Inc., of Waltham, Mass., appointed Marc Schegerin chief financial officer and chief operating officer.

No Comments